![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 38/05 | (2006.01) |
A61K 47/12 | (2006.01) | ||
A61K 47/26 | (2006.01) | ||
F26B 5/06 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Number of the document | 2701720 |
(13) | Kind of document | T |
(96) | European patent application number | 12718949.6 |
Date of filing the European patent application | 2012-04-25 | |
(97) | Date of publication of the European application | 2014-03-05 |
(45) | Date of publication and mention of the grant of the patent | 2017-07-12 |
(46) | Date of publication of the claims translation | 2017-11-10 |
(86) | Number | PCT/EP2012/057577 |
Date | 2012-04-25 |
(87) | Number | WO 2012/146625 |
Date | 2012-11-01 |
(30) | Number | Date | Country code |
1150371 | 2011-04-28 | SE | |
201161535126 P | 2011-09-15 | US |
(72) |
SPIRA, Jack, SE
LEHMANN, Fredrik, SE
|
(73) |
Oncopeptides Innovation AB ,
Luntmakargatan 46, 111 37 Stockholm,
SE
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Liofilizuotas citotoksinių dipeptidų preparatas |
LYOPHILIZED PREPARATION OF CYTOTOXIC DIPEPTIDES |
Payment date | Validity (years) | Amount | |
2025-03-21 | 14 | 289.00 EUR |
2026-04-25 |